生物活性 | |||
---|---|---|---|
描述 | Sphingosine-1-phosphate (S1P) is a metabolic product of sphingolipid and it activates five G protein-coupled receptors, S1P1-5. S1P-agonist-1 has been identified as a potent S1P1 receptor agonist with an IC50 value of 0.6nM. It shows less affinity for S1P4 and S1P5 with IC50 values of 70 and 1.0nM, respectively. The IC50 value for S1P3 is 12μM. The half-lives (t1/2) of S1P-agonist-1 in rats was 8.5h. The minimal single dose of S1P-agonist-1 required for the maximal sequestration of peripheral blood lymphocytes (PBL) was 10, 0.5, and 0.5mg/kg (p.o.) in mice, rats, and dogs, respectively. The pharmacodynamic ED50 for S1P-agonist-1 in the PBL lowering response assay was 0.03mpk (p.o.). In a rat skin allograft model, the combined treatment of S1P-agonist-1 (5.0mpk p.o. per day, 28 days) and CsA (1mpk/day, i.p.) showed the median graft survival times of 22 days[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.21mL 2.44mL 1.22mL |
24.42mL 4.88mL 2.44mL |
参考文献 |
---|